Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 PCR
1.2.3 DNA Sequencing
1.2.4 NGS
1.3 Market by Application
1.3.1 Global Molecular Diagnosis and Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diagnostic Laboratories
1.3.3 Research & Academic Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnosis and Therapy Market Perspective (2018-2033)
2.2 Molecular Diagnosis and Therapy Growth Trends by Region
2.2.1 Global Molecular Diagnosis and Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Molecular Diagnosis and Therapy Historic Market Size by Region (2018-2023)
2.2.3 Molecular Diagnosis and Therapy Forecasted Market Size by Region (2024-2033)
2.3 Molecular Diagnosis and Therapy Market Dynamics
2.3.1 Molecular Diagnosis and Therapy Industry Trends
2.3.2 Molecular Diagnosis and Therapy Market Drivers
2.3.3 Molecular Diagnosis and Therapy Market Challenges
2.3.4 Molecular Diagnosis and Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnosis and Therapy Players by Revenue
3.1.1 Global Top Molecular Diagnosis and Therapy Players by Revenue (2018-2023)
3.1.2 Global Molecular Diagnosis and Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Diagnosis and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnosis and Therapy Revenue
3.4 Global Molecular Diagnosis and Therapy Market Concentration Ratio
3.4.1 Global Molecular Diagnosis and Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis and Therapy Revenue in 2022
3.5 Molecular Diagnosis and Therapy Key Players Head office and Area Served
3.6 Key Players Molecular Diagnosis and Therapy Product Solution and Service
3.7 Date of Enter into Molecular Diagnosis and Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnosis and Therapy Breakdown Data by Type
4.1 Global Molecular Diagnosis and Therapy Historic Market Size by Type (2018-2023)
4.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2024-2033)
5 Molecular Diagnosis and Therapy Breakdown Data by Application
5.1 Global Molecular Diagnosis and Therapy Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Molecular Diagnosis and Therapy Market Size (2018-2033)
6.2 North America Molecular Diagnosis and Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Molecular Diagnosis and Therapy Market Size by Country (2018-2023)
6.4 North America Molecular Diagnosis and Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnosis and Therapy Market Size (2018-2033)
7.2 Europe Molecular Diagnosis and Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Molecular Diagnosis and Therapy Market Size by Country (2018-2023)
7.4 Europe Molecular Diagnosis and Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnosis and Therapy Market Size (2018-2033)
8.2 Asia-Pacific Molecular Diagnosis and Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnosis and Therapy Market Size (2018-2033)
9.2 Latin America Molecular Diagnosis and Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Molecular Diagnosis and Therapy Market Size by Country (2018-2023)
9.4 Latin America Molecular Diagnosis and Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnosis and Therapy Market Size (2018-2033)
10.2 Middle East & Africa Molecular Diagnosis and Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnosis and Therapy Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Molecular Diagnosis and Therapy Introduction
11.2.4 Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.2.5 Agilent Technologies Recent Development
11.3 Becton, Dickinson and Company
11.3.1 Becton, Dickinson and Company Company Detail
11.3.2 Becton, Dickinson and Company Business Overview
11.3.3 Becton, Dickinson and Company Molecular Diagnosis and Therapy Introduction
11.3.4 Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.3.5 Becton, Dickinson and Company Recent Development
11.4 Biomérieux Sa
11.4.1 Biomérieux Sa Company Detail
11.4.2 Biomérieux Sa Business Overview
11.4.3 Biomérieux Sa Molecular Diagnosis and Therapy Introduction
11.4.4 Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.4.5 Biomérieux Sa Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Detail
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Molecular Diagnosis and Therapy Introduction
11.5.4 Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.5.5 Danaher Corporation Recent Development
11.6 Diasorin
11.6.1 Diasorin Company Detail
11.6.2 Diasorin Business Overview
11.6.3 Diasorin Molecular Diagnosis and Therapy Introduction
11.6.4 Diasorin Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.6.5 Diasorin Recent Development
11.7 Grifols
11.7.1 Grifols Company Detail
11.7.2 Grifols Business Overview
11.7.3 Grifols Molecular Diagnosis and Therapy Introduction
11.7.4 Grifols Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.7.5 Grifols Recent Development
11.8 Hologic
11.8.1 Hologic Company Detail
11.8.2 Hologic Business Overview
11.8.3 Hologic Molecular Diagnosis and Therapy Introduction
11.8.4 Hologic Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.8.5 Hologic Recent Development
11.9 Illumina
11.9.1 Illumina Company Detail
11.9.2 Illumina Business Overview
11.9.3 Illumina Molecular Diagnosis and Therapy Introduction
11.9.4 Illumina Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.9.5 Illumina Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Detail
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Molecular Diagnosis and Therapy Introduction
11.10.4 Qiagen Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.10.5 Qiagen Recent Development
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Detail
11.11.2 Roche Diagnostics Business Overview
11.11.3 Roche Diagnostics Molecular Diagnosis and Therapy Introduction
11.11.4 Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.11.5 Roche Diagnostics Recent Development
11.12 Siemens AG
11.12.1 Siemens AG Company Detail
11.12.2 Siemens AG Business Overview
11.12.3 Siemens AG Molecular Diagnosis and Therapy Introduction
11.12.4 Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.12.5 Siemens AG Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Detail
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Molecular Diagnosis and Therapy Introduction
11.13.4 Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2018-2023)
11.13.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Molecular Diagnosis and Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of PCR
Table 3. Key Players of DNA Sequencing
Table 4. Key Players of NGS
Table 5. Global Molecular Diagnosis and Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Molecular Diagnosis and Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Molecular Diagnosis and Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Molecular Diagnosis and Therapy Market Share by Region (2018-2023)
Table 9. Global Molecular Diagnosis and Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Molecular Diagnosis and Therapy Market Share by Region (2024-2033)
Table 11. Molecular Diagnosis and Therapy Market Trends
Table 12. Molecular Diagnosis and Therapy Market Drivers
Table 13. Molecular Diagnosis and Therapy Market Challenges
Table 14. Molecular Diagnosis and Therapy Market Restraints
Table 15. Global Molecular Diagnosis and Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Molecular Diagnosis and Therapy Market Share by Players (2018-2023)
Table 17. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2022)
Table 18. Ranking of Global Top Molecular Diagnosis and Therapy Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Molecular Diagnosis and Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnosis and Therapy Product Solution and Service
Table 22. Date of Enter into Molecular Diagnosis and Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnosis and Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Molecular Diagnosis and Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Molecular Diagnosis and Therapy Revenue Market Share by Type (2024-2033)
Table 28. Global Molecular Diagnosis and Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Molecular Diagnosis and Therapy Revenue Market Share by Application (2018-2023)
Table 30. Global Molecular Diagnosis and Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Molecular Diagnosis and Therapy Revenue Market Share by Application (2024-2033)
Table 32. North America Molecular Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Molecular Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Molecular Diagnosis and Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Molecular Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Molecular Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Molecular Diagnosis and Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Molecular Diagnosis and Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Molecular Diagnosis and Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Molecular Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Molecular Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Molecular Diagnosis and Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Molecular Diagnosis and Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Molecular Diagnosis and Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Molecular Diagnosis and Therapy Product
Table 50. Abbott Laboratories Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Agilent Technologies Company Detail
Table 53. Agilent Technologies Business Overview
Table 54. Agilent Technologies Molecular Diagnosis and Therapy Product
Table 55. Agilent Technologies Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 56. Agilent Technologies Recent Development
Table 57. Becton, Dickinson and Company Company Detail
Table 58. Becton, Dickinson and Company Business Overview
Table 59. Becton, Dickinson and Company Molecular Diagnosis and Therapy Product
Table 60. Becton, Dickinson and Company Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 61. Becton, Dickinson and Company Recent Development
Table 62. Biomérieux Sa Company Detail
Table 63. Biomérieux Sa Business Overview
Table 64. Biomérieux Sa Molecular Diagnosis and Therapy Product
Table 65. Biomérieux Sa Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 66. Biomérieux Sa Recent Development
Table 67. Danaher Corporation Company Detail
Table 68. Danaher Corporation Business Overview
Table 69. Danaher Corporation Molecular Diagnosis and Therapy Product
Table 70. Danaher Corporation Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 71. Danaher Corporation Recent Development
Table 72. Diasorin Company Detail
Table 73. Diasorin Business Overview
Table 74. Diasorin Molecular Diagnosis and Therapy Product
Table 75. Diasorin Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 76. Diasorin Recent Development
Table 77. Grifols Company Detail
Table 78. Grifols Business Overview
Table 79. Grifols Molecular Diagnosis and Therapy Product
Table 80. Grifols Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 81. Grifols Recent Development
Table 82. Hologic Company Detail
Table 83. Hologic Business Overview
Table 84. Hologic Molecular Diagnosis and Therapy Product
Table 85. Hologic Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 86. Hologic Recent Development
Table 87. Illumina Company Detail
Table 88. Illumina Business Overview
Table 89. Illumina Molecular Diagnosis and Therapy Product
Table 90. Illumina Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 91. Illumina Recent Development
Table 92. Qiagen Company Detail
Table 93. Qiagen Business Overview
Table 94. Qiagen Molecular Diagnosis and Therapy Product
Table 95. Qiagen Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 96. Qiagen Recent Development
Table 97. Roche Diagnostics Company Detail
Table 98. Roche Diagnostics Business Overview
Table 99. Roche Diagnostics Molecular Diagnosis and Therapy Product
Table 100. Roche Diagnostics Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 101. Roche Diagnostics Recent Development
Table 102. Siemens AG Company Detail
Table 103. Siemens AG Business Overview
Table 104. Siemens AG Molecular Diagnosis and Therapy Product
Table 105. Siemens AG Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 106. Siemens AG Recent Development
Table 107. Thermo Fisher Scientific Company Detail
Table 108. Thermo Fisher Scientific Business Overview
Table 109. Thermo Fisher Scientific Molecular Diagnosis and Therapy Product
Table 110. Thermo Fisher Scientific Revenue in Molecular Diagnosis and Therapy Business (2018-2023) & (US$ Million)
Table 111. Thermo Fisher Scientific Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnosis and Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Molecular Diagnosis and Therapy Market Share by Type: 2022 VS 2033
Figure 3. PCR Features
Figure 4. DNA Sequencing Features
Figure 5. NGS Features
Figure 6. Global Molecular Diagnosis and Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Molecular Diagnosis and Therapy Market Share by Application: 2022 VS 2033
Figure 8. Diagnostic Laboratories Case Studies
Figure 9. Research & Academic Laboratories Case Studies
Figure 10. Molecular Diagnosis and Therapy Report Years Considered
Figure 11. Global Molecular Diagnosis and Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Molecular Diagnosis and Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Molecular Diagnosis and Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Molecular Diagnosis and Therapy Market Share by Players in 2022
Figure 15. Global Top Molecular Diagnosis and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnosis and Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Molecular Diagnosis and Therapy Revenue in 2022
Figure 17. North America Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Molecular Diagnosis and Therapy Market Share by Country (2018-2033)
Figure 19. United States Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Molecular Diagnosis and Therapy Market Share by Country (2018-2033)
Figure 23. Germany Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Molecular Diagnosis and Therapy Market Share by Region (2018-2033)
Figure 31. China Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Molecular Diagnosis and Therapy Market Share by Country (2018-2033)
Figure 39. Mexico Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Molecular Diagnosis and Therapy Market Share by Country (2018-2033)
Figure 43. Turkey Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Molecular Diagnosis and Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 46. Agilent Technologies Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 47. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 48. Biomérieux Sa Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 49. Danaher Corporation Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 50. Diasorin Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 51. Grifols Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 52. Hologic Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 53. Illumina Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 54. Qiagen Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 55. Roche Diagnostics Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 56. Siemens AG Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnosis and Therapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed